Vir Biotechnology (VIR) Other Accumulated Expenses (2018 - 2023)
Vir Biotechnology's Other Accumulated Expenses came in at $9.72 million for Q1 2023, down 90.6% from $103.32 million a year earlier and down 23.5% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Other Accumulated Expenses (2018 - 2023) Analysis & Trends
At the end of FY2022, Vir Biotechnology's Other Accumulated Expenses was $12.71 million, down 78.3% from FY2021.
- Other Accumulated Expenses carries a four-year compound annual growth rate of 47.9% (FY2018 to FY2022).
- Going back by year, Other Accumulated Expenses was $58.67 million in FY2021, $805,000 in FY2020 (-30.4%), $1.16 million in FY2019 (-56.5%) and $2.66 million in FY2018.
- The Q1 2023 figure represents the lowest quarterly Other Accumulated Expenses since Q3 2021.
- Year-over-year, Other Accumulated Expenses increased in three of the last five quarters, with growth averaging 269.1%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2021 (growth of 809.7%), and the weakest in Q1 2023 (a decline of 90.6%).
- Business Quant data shows VIR's Other Accumulated Expenses at $12.71 million (Q4 2022), $27.77 million (Q3 2022) and $48.28 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 9.72 Mn |
| Dec 31, 2022 | 12.71 Mn |
| Sep 30, 2022 | 27.77 Mn |
| Jun 30, 2022 | 48.28 Mn |
| Mar 31, 2022 | 103.32 Mn |
| Dec 31, 2021 | 58.67 Mn |
| Sep 30, 2021 | 8.07 Mn |
| Jun 30, 2021 | 3.33 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 805,000.00 |
| Sep 30, 2020 | 887,000.00 |
| Jun 30, 2020 | 595,000.00 |
| Mar 31, 2020 | 774,000.00 |
| Dec 31, 2019 | 1.16 Mn |
| Sep 30, 2019 | 1.73 Mn |
| Dec 31, 2018 | 2.66 Mn |
API Access
Vir Biotechnology Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();